Quick Takeaways
- James Huang filed SCHEDULE 13G/A for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI).
- Disclosed ownership: 14%.
- Date of event: 30 Jun 2025.
James Huang - 30 Jun 2025 SCHEDULE 13G/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)
- Filing Manager
- James Huang
- Reporting Manager
- James Huang
- Symbol
- CASI
- Shares outstanding
- 15,663,558 shares
- Disclosed Ownership
- 2,161,571 shares
- Ownership
- 14%
- Form type
- SCHEDULE 13G/A
- Filing time
- 23 Jul 2025, 09:39:43 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"James Huang disclosed 14% ownership in CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 23 Jul 2025, 09:39.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Panacea Venture Healthcare Fund II, L.P. | 13% | 2,050,000 | 0 | 2,050,000 | By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang | James Huang, Founding Managing Partner | |
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 13% | 2,050,000 | 0 | 2,050,000 | By: Panacea Innovation Limited, its sole owner, /s/ James Huang | James Huang, Founding Managing Partner | |
| Panacea Innovation Limited | 13% | 2,050,000 | 0 | 2,050,000 | /s/ James Huang | James Huang, Founding Managing Partner | |
| James Huang | 14% | 2,161,571 | 111,571 | 2,050,000 | /s/ James Huang | James Huang |